Theseus Pharmaceuticals Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2020
Net Income	-15.82	-19.17	-27.57	-9.36	-2.25	-1.42	Upgrade
Change in Accounts Payable	-623.03	80.65	-1.38	-3.42	13.71	0.01	Upgrade
Change in Other Net Operating Assets	-114.89	-193.09	-135.67	-111.2	-12.09	-	Upgrade
Other Operating Activities	-3.76	-1.2	-9.33	-8.94	-0.4	-0.89	Upgrade
Operating Cash Flow	-757.5	-132.81	-173.94	-132.92	-1.02	-2.3	Upgrade
Capital Expenditures	-1,210	-1,316	-300.36	-872.98	-331.35	-92.03	Upgrade
Other Investing Activities	0.02	0.03	0.56	-	-	-	Upgrade
Investing Cash Flow	-1,210	-1,316	-299.8	-872.98	-331.35	-92.03	Upgrade
Short-Term Debt Issued	-	1,148	-	-	-	-	Upgrade
Long-Term Debt Issued	-	122	300	-	-	-	Upgrade
Total Debt Issued	1,872	1,270	300	-	-	-	Upgrade
Net Debt Issued (Repaid)	1,872	1,270	300	-	-	-	Upgrade
Issuance of Common Stock	324.94	408.75	1,521	877.51	446.67	87.38	Upgrade
Other Financing Activities	-212.4	-85.24	-1,307	-	-	-	Upgrade
Financing Cash Flow	1,985	1,593	514.07	877.51	446.67	87.38	Upgrade
Miscellaneous Cash Flow Adjustments	-0	-	-	-0	-	-	Upgrade
Net Cash Flow	17.46	144.72	40.32	-128.39	114.3	-6.96	Upgrade
Free Cash Flow	-1,968	-1,449	-474.31	-1,006	-332.37	-94.33	Upgrade
Free Cash Flow Per Share	-10.34	-8.24	-9.81	-22.28	-7.36	-2.09	Upgrade
Cash Interest Paid	127.17	-	-	-	-	0	Upgrade
Cash Income Tax Paid	3.73	1.13	8.77	8.94	0.4	0.89	Upgrade
Levered Free Cash Flow	-	-1,417	-461.81	-998.13	-344.35	-93.8	Upgrade
Unlevered Free Cash Flow	-	-1,417	-461.81	-998.13	-344.35	-93.8	Upgrade
Change in Net Working Capital	-	87.1	140.71	115.75	11.6	0.88	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.